Legend Biotech Corporation (FRA:9LB)

Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of EUR 4.26 billion. The enterprise value is 3.76 billion.

Market Cap	4.26B
Enterprise Value	3.76B

Important Dates

The next estimated earnings date is Wednesday, March 11, 2026.

Earnings Date	Mar 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	182.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	121.46
PS Ratio	5.50
PB Ratio	4.95
P/TBV Ratio	4.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.42
EV / Sales	4.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.40

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.41.

Current Ratio	2.86
Quick Ratio	2.76
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-2.17
Interest Coverage	-9.58

Financial Efficiency

Return on equity (ROE) is -22.53% and return on invested capital (ROIC) is -8.27%.

Return on Equity (ROE)	-22.53%
Return on Assets (ROA)	-6.92%
Return on Invested Capital (ROIC)	-8.27%
Return on Capital Employed (ROCE)	-14.92%
Revenue Per Employee	267,165
Profits Per Employee	-70,447
Employee Count	2,600
Asset Turnover	0.53
Inventory Turnover	29.45

Taxes

In the past 12 months, Legend Biotech has paid 14.67 million in taxes.

Income Tax	14.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.80%
50-Day Moving Average	26.94
200-Day Moving Average	29.85
Relative Strength Index (RSI)	35.17
Average Volume (20 Days)	72

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.45

Income Statement

In the last 12 months, Legend Biotech had revenue of EUR 774.78 million and -204.30 million in losses. Loss per share was -1.11.

Revenue	774.78M
Gross Profit	113.08M
Operating Income	-162.67M
Pretax Income	-189.63M
Net Income	-204.30M
EBITDA	-154.47M
EBIT	-162.67M
Loss Per Share	-1.11

Balance Sheet

The company has 845.99 million in cash and 349.65 million in debt, giving a net cash position of 496.34 million.

Cash & Cash Equivalents	845.99M
Total Debt	349.65M
Net Cash	496.34M
Net Cash Per Share	n/a
Equity (Book Value)	861.90M
Book Value Per Share	4.67
Working Capital	689.03M

Cash Flow

In the last 12 months, operating cash flow was -144.95 million and capital expenditures -15.86 million, giving a free cash flow of -160.81 million.

Operating Cash Flow	-144.95M
Capital Expenditures	-15.86M
Free Cash Flow	-160.81M
FCF Per Share	n/a

Margins

Gross margin is 14.60%, with operating and profit margins of -21.00% and -26.37%.

Gross Margin	14.60%
Operating Margin	-21.00%
Pretax Margin	-24.48%
Profit Margin	-26.37%
EBITDA Margin	-19.94%
EBIT Margin	-21.00%
FCF Margin	n/a

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	-0.86%
Earnings Yield	-4.79%
FCF Yield	-3.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Legend Biotech has an Altman Z-Score of 4.93 and a Piotroski F-Score of 4.

Altman Z-Score	4.93
Piotroski F-Score	4